Renown Nigerian virologist, Professor
Tomori, who is President,
He said the meetings in US would provide a rich base for the
In the email to Daily Independent, he said, "I had meetings today (Tuesday) with representatives of US government and some African leaders, then moved on to another meeting on Ebola with CDC, USAID,
"I am working with the Ebola team in
Although the virus had only been confirmed in two cases in
This was taken to a higher dimension by the government of
The committee was constituted after former Chairman of
The committee to be co-chaired by the Director-General of the
Meanwhile, newly appointed Vice Chancellor of
According to Adikwu, what might be new about the virus is that the current strain may have become difficult to curtail, saying the solution lies in the laboratories and hands of scientists.
In a response to Daily Independent's query, Adikwu said, "I remember hearing about Ebola virus far back in 1976 or so as a primary school pupil. It has always been curtailed. It is just that the current strain of the virus is difficult to curtail."
Explaining further, he said, "Like most viral infections, they are intracellular and as such difficult to eliminate using common antiviral agents. The best option is still to look for a way of developing a vaccine against the virus."
The NLNG science prize winner also disclosed that many viral infections are self-limiting, in which case if they do not kill an infected person, they wane off naturally, a situation that also applies to Ebola.
He said, "While, developing drugs against the viral particles should not be ruled out, the easier way of controlling such epidemics is to seek for vaccine against the virus."
Similarly, Head of
In a phone interview with Daily Independent from his Umudike base, Ezeibe said, "Nigerians need not fear. What we need is a collaboration with laboratories researching on Ebola Virus."
Ezeibe also said a research he did on the synthetic Aluminum-magnesium silicate (AMS) could provide a basic template for treating Ebola effectively.
He said, "The synthetic Aluminum-Magnesium Silicate (AMS) we invented in
He said the AMS cured Newcastle disease and Gumboro disease in chickens and Canine parvovirus disease in dogs, adding, "In ongoing clinical trials on HIV\AIDS it has recorded a cure. The patient had his RNA count reduced from 1000 copies/ml to 40copies/ml after 2months treatment and once RNA is less than 50 copies/ml a person is HIV negative."
The agency announced on Tuesday that the team will comprise staff from the
It also announced an additional
Most Popular Stories
- Stocks Close Out Best Week in Nearly 2 Years
- Microsoft Earnings Drive Stocks Higher
- Do Voters Want Compromise?
- Timeline for New York Ebola Doctor
- 'Kissing Congressman' Admits Mistake in Reelection Bid
- Clinton Rallies New England Women
- Ebola in New York, Mali Raises Travel Jitters
- Market Jolt Offers a Reality Check for Investors
- Tech Workers Needed in South Florida
- Steris to Add 100 Jobs in Birmingham